Dr. Thomas P. Bravo, MD

Dr. Bravo practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Dr. Bravo's NPI, 1952629149, was assigned on May 12, 2010. Dr. Bravo graduated from Loma Linda University School Of Medicine in 2010. Dr. Bravo holds California license A135297.

Dr. Bravo's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Dr. Bravo's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Dr. Bravo is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Bravo to 2 more group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Bravo's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bravo practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Bravo's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Bravo is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Bravo's licenses on file in 2 states: California and Arizona.

Dmand AI lists cerebrovascular disease, fibromyalgia and chronic pain, head injury, migraine and chronic headache, muscle pain, fibromyalgia, and limb pain and thoracic spine disorders among the conditions Dr. Bravo treats.

CMS data shows 7,036 Medicare services from Dr. Bravo across 7 procedure codes in 2024, for 132 Medicare patients. Medicare paid $51,869 for them.

CMS counts 132 Medicare patients who saw Dr. Bravo in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 1.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bravo's median patient age at 52, with 74% women.

In 2024, Dr. Bravo wrote 1,110 Medicare Part D claims for 182 patients. 63% of them were for generic drugs. CMS names the drug for 876 of them, across 27 drugs with 11 or more claims each, at $377,515 in total drug cost. In 2023, CMS named 1,092 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bravo for performance year 2024, reported as part of a group. Dr. Bravo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bravo as offering telehealth.

Dmand AI links 6 papers to Dr. Bravo, published from 2007 to 2016. The most frequent topics are Brain Injuries, Neuroprotective Agents and Neurosurgical Procedures. Dr. Bravo has published most often in Neurologist. Dr. Bravo's most frequent co-authors are Bart M. Demaerschalk, MD, Dean M. Wingerchuk, MD and Dan J. Capampangan, MD.

CMS Open Payments shows 19 general payments to Dr. Bravo from 7 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $305.

Dr. Bravo graduated from Loma Linda University School Of Medicine in 2010. Dr. Bravo is a member of AOA, AAN, American Headache Society and California Medical Association.

Dr. Bravo is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.